Yang Sai
Union Hospital(CN)First Affiliated Hospital of Hunan University of Traditional Chinese Medicine(CN)Huazhong University of Science and Technology(CN)
Publications by Year
Research Areas
Pharmacogenetics and Drug Metabolism, Lung Cancer Treatments and Mutations, PI3K/AKT/mTOR signaling in cancer, Chronic Lymphocytic Leukemia Research, Chronic Myeloid Leukemia Treatments
Most-Cited Works
- → Discovery of fruquintinib, a potent and highly selective small molecule inhibitor of VEGFR 1, 2, 3 tyrosine kinases for cancer therapy(2014)151 cited
- → Assessment of specificity of eight chemical inhibitors using cDNA-expressed cytochromes P450(2000)137 cited
- → Discovery of (S)-1-(1-(Imidazo[1,2-a]pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-[1,2,3]triazolo[4,5-b]pyrazine (Volitinib) as a Highly Potent and Selective Mesenchymal–Epithelial Transition Factor (c-Met) Inhibitor in Clinical Development for Treatment of Cancer(2014)133 cited
- → Pharmacokinetic characterization of ginsenoside Rh2, an anticancer nutrient from ginseng, in rats and dogs(2009)125 cited
- → Diminishing microbiome richness and distinction in the lower respiratory tract of lung cancer patients: A multiple comparative study design with independent validation(2019)95 cited